SYRE Live signals | Maximize Profits with Getagraph.com

BUY 120949 min ago

@ $22.52

Issued: 14 Feb 2024 @ 15:56

Return: 46.63%

Previous signal: Feb 14 - 09:38

Previous signal: Sell

Return: -2.04 %

Live Chart Being Loaded With Signals

Commentary (8 May 2024 @ 16:00):

Stats
Today's Volume	245 077
Average Volume	508 554
Market Cap	1.21B
EPS	$-3.43 ( 2023-11-09 )
Next earnings date	( $-0.900 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.101 (0.31%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-25	Fairmount Funds Management Llc	Buy	3 639 680	Common Stock
2024-04-25	Fairmount Funds Management Llc	Sell	90 992	Series A Preferred Stock
2024-02-15	Turtle Cameron	Buy	400	Common Stock
2024-02-01	Mckenna Mark C.	Buy	40 000	Stock Option (Right to Buy)
2024-02-01	Mckenna Mark C.	Sell	477 000	Stock Option (Right to Buy)

INSIDER POWER
12.77
Last 11 transactions
Buy: 4 513 535 \| Sell: 4 003 472

Volume Correlation

Long: 0.43 (neutral)

Short: -0.64 (weak negative)

Signal:(66.033) Neutral

Spyre Therapeutics, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Spyre Therapeutics, Inc. Correlation - Currency/Commodity

0.21
( neutral )

0.51
( weak )

0.00
( neutral )

0.48
( neutral )

0.29
( neutral )

-0.50
( weak negative )

Spyre Therapeutics, Inc. Financials

Annual	2023
Revenue:	$886 000
Gross Profit:	$-78 000.00 (-8.80 %)
EPS:	$-49.12

FY	2023
Revenue:	$886 000
Gross Profit:	$-78 000.00 (-8.80 %)
EPS:	$-49.12

Financial Reports:

No articles found.

Spyre Therapeutics, Inc.

Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. The company's pipeline includes extended half-life antibodies targeting a4ß7, TL1A, and IL-23. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. Spyre Therapeutics, Inc. was founded in 2013 and is based in Waltham, Massachusetts.

Realtime updates for Spyre Therapeutics, Inc. [SYRE]

Upcoming Earnings Alert